Broadwood Capital’s Asterias Biotherapeutics Warrants AST.WS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
– Sell
-328,205
Closed -$164K – 8
2017
Q2
$164K Hold
328,205
– – 0.03% 8
2017
Q1
$140K Hold
328,205
– – 0.03% 8
2016
Q4
$179K Hold
328,205
– – 0.03% 9
2016
Q3
$171K Buy
+328,205
New +$89.7K 0.03% 9

Broadwood Capital's AST.WS Position: Q3 2017 in Review

Broadwood Capital sold out of Asterias Biotherapeutics Warrants (AST.WS) in Q3 2017, closing a stake of 328,205 shares — an estimated $164K sold.

Broadwood Capital first reported a position in AST.WS in Q3 2016 and held it in 4 quarters. The position peaked at $179K in Q4 2016. 3 funds tracked by Wall St. Rank hold AST.WS as of Q3 2017.

  • Broadwood Capital reported no remaining Asterias Biotherapeutics Warrants position as of Q3 2017 after selling out during the quarter.
  • Broadwood Capital sold 328,205 Asterias Biotherapeutics Warrants shares in Q3 2017, an estimated $164K.
  • Broadwood Capital first reported a position in Asterias Biotherapeutics Warrants in Q3 2016 and held it in 4 quarters.
  • Broadwood Capital's Asterias Biotherapeutics Warrants position peaked at $179K in Q4 2016.
  • 3 funds tracked by Wall St. Rank held Asterias Biotherapeutics Warrants as of Q3 2017.

Based on Broadwood Capital's 13F filing for Q3 2017, filed 14 Nov 2017.